当前位置: 首页 > 期刊 > 《第四军医大学学报》 > 2004年第19期
编号:10872726
大剂量常规分次与低分割三维适形放射治疗原发性非小细胞肺癌
http://www.100md.com 《第四军医大学学报》 2004年第19期
非小细胞肺,,癌,非小细胞肺;,放射疗法;,三维适形放射治疗;,分割,0引言,1对象和方法,2结果,3讨论,【参考文献】
     Highdose conventional fractionted and hypofractionted of threedimensional conformal radiotherapy for primary nonsmall cell cancer

    DUAN YongJian, TANG WenChun, HAN XiaoLi, QI LiXia, WANG ZhiWei

    epartment of Radiotherapy, First Hospital, Henan University, Kaifeng 475001, China

    【Abstract】 AIM: To assess the responses and side effects of conventional fractionation (CF) regimen and hypo fractionation (HF) regimen in threedimensional conformal radiotherapy (3DCRT) for primary nonsmall cell lung cancer. METHODS: Eightyseven patients with primary nonsmall cell lung cancer who were suitable for 3DCRT were randomly divided into two groups: 44 cases entered in the CF group and 43 cases in the HF group. The CF group received 5-7 Gy per day, 5 d per week, to a total dose of 36-60 Gy, the HF group were treated with the dose as that of the CF group, but once in two days. Those patients of central lung cancer and mediastinal lumph nodes lung cancer received conventional externalbeam radiotherapy at the same time, with a total dose of 40-46 Gy. RESULTS: The local control rates at 1, 2 and 3 years were respectively 84.1%, 65.9% and 52.3% in the CF group and those in the HF group were respectively 79.1%, 51.2% and 27.9%. There were significant differences between the two groups (χ2=4.64, P=0.035). The surgical rates at 1, 2 and 3 years were respectively 77.3%, 59.1% and 36.4% in the CF group and those in the HF group were 60.5%, 46.5% and 18.6%. The difference was significant (χ2=4.30, P=0.041). The incidences of grade 1 and 2 acute esophagitis in the CF group were 20 cases and 16 cases in the HF group (χ2=0.61, P=0.45). The incidences of grade 1 and 2 Radiotion Pneum onitis in the CF group were 10 cases and 7 cases in the HF group (χ2=0.58, P=0.46). CONCLUSION: The CF regimen of 3DCRT is superior to the HF regimen of 3DCRT for primary nonsmall cell lung cancer. ......

您现在查看是摘要页,全文长 8293 字符